Rigel Pharmaceuticals, Inc. (RIGL)
25.94
-0.66
(-2.48%)
USD |
NASDAQ |
Mar 13, 15:08
Rigel Pharmaceuticals Shareholders Equity (Quarterly) : 391.48M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Nektar Therapeutics | 85.09M |
| Ironwood Pharmaceuticals, Inc. | -261.84M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Amicus Therapeutics, Inc. | 274.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 560.62M |
| Total Liabilities (Quarterly) | 169.14M |
| Debt to Equity Ratio | 0.1362 |
| Current Ratio | 2.420 |
| Net Debt Paydown Yield | 0.18% |